[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-368774-105":59,"doc-detail-368774-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","regulation-of-emt-met-and-chemoresistance-by-the-lc3cer-synthase-b3gnt5","Regulation of EMT-MET and chemoresistance by the Lc3Cer-synthase B3GNT5","","Glycosphingolipids (GSL) form critical plasma-membrane components that shape cancer malignancy by influencing processes linked to epithelial to mesenchymal transition (EMT), receptor tyrosine kinase signaling, and multi-drug chemoresistance. In the GSL biosynthetic pathway, B3GNT5 is identified as a key regulator governing flux into lactoside and neolactoside series. Data mining and CRISPR-Cas9 partial depletion in HeLa cells show that B3GNT5 copy number gain and overexpression are common and predict poor prognosis, while depletion increases GlcCer/LacCer, chemoresistance, and EMT marker changes with broad RTK activation decreases after serum stimulation. Functional targeting supports B3GNT5 as a therapeutic intervention point.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/regulation-of-emt-met-and-chemoresistance-by-the-lc3cer-synthase-b3gnt5/368774/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/regulation-of-emt-met-and-chemoresistance-by-the-lc3cer-synthase-b3gnt5/368774.png","ImageObject",300,407,{"name":92,"@type":93},"Mabel","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":8},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What role does B3GNT5 play in glycosphingolipid (GSL) metabolism?","Question",{"text":112,"@type":113},"B3GNT5 regulates GSL biosynthesis by controlling flux into the lactoside and neolactoside series through production of the Lc3Cer precursor.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was B3GNT5 function tested in cancer cells?",{"text":117,"@type":113},"Public genetic data were mined for lesions at the B3GNT5 locus and expression effects on outcomes, and HeLa cells were partially depleted of B3GNT5 using CRISPR-Cas9 to assess cancer-associated phenotypes.",{"name":119,"@type":110,"acceptedAnswer":120},"What phenotypic effects occur when B3GNT5 is partially depleted?",{"text":121,"@type":113},"Partial depletion increased GlcCer and LacCer, raised chemoresistance, altered EMT marker expression, and decreased activation of multiple RTKs after serum stimulation.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},368774,1790178488,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":8,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":129,"read_time":36,"preview_page_count":19,"preview_urls":144},7971474920318,"https://ap-avatar.wpscdn.com/avatar/74000ee537e6b0ca360?x-image-process=image/resize,m_fixed,w_180,h_180&k=1788430171632181674","Clark etal. BMC Cancer (2025) 25:1356 BMC Cancer  \n[https://doi.org/10.1186/s12885-025-14717-5](https://doi.org/10.1186/s12885-025-14717-5)  \nRESEARCH Open Access  \nRegulation of EMT-MET and chemoresistance by the Lc3Cer-synthase B3GNT5  \nLaura E. Clark 1†, Katherine Hylton Rorie 1†, Amanda J. G. Dickinson 1 and Santiago Lima 1,2*  \nAbstract  \nBackground Glycosphingolipids (GSL) are essential components of the plasma membrane where they are known to play key structural and functional roles and are known to influence molecular processes involved in cancer malignancy, including multi-drug chemoresistance, the epithelial to mesenchymal transition (EMT), and the activation or receptor tyrosine kinases (RTK) . Thus, investigating and understanding how GSLs are regulated in cancer and the impact they have on malignancy have important therapeutic potential. In the GSL biosynthetic pathway, one critical regulator oftwo of the four major branches of GSLs is the gene product of B3GNT5, which produces the precursor for all GSLs in the lactoside and neolactoside series.  \nMethods Publicly available data was mined to determine the types and prevalence of genetic lesions at the B3GNT5 locus in various cancers, and to assess the impact of increased expression on patient outcomes. HeLa cells in which B3GNT5 was partially depleted using CRISPR-Cas9 approaches were used to determine how its expression levels impacted several phenotypic properties associated with cancer malignancy. Mass spectrometry was used to assess the effect of B3GNT5 on the level s ofthe Lc3Cer precursors glucosylceramide (GlcCer) and lactosylceramide (LacCer) . Results B3GNT5 copy number gain and overexpression are widespread across human cancers and are significantly associated with poor prognosis. Partial depletion of B3GNT5 in HeLa cells led to accumulation of GlcCer and LacCer, increased chemoresistance, altered EMT marker expression, and decreased activation of multiple RTKs following stimulation with serum—suggesting broad signaling and phenotypic shifts.  \nConclusions B3GNT5 is frequently altered in human cancers and correlates with adverse clinical outcomes. Functional depletion reveals its key role in regulating glycosphingolipid metabolism, signaling, and malignant phenotypes. These findings support B3GNT5 as an important target for therapeutic intervention in cancer. Keywords B3GNT5, Glycosphingolipid, Cancer, Chemoresistance, EMT, Lactosylceramide, Glucosylceramide  \n†Laura E. Clark and Katherine Hylton Rorie have contributed equally to this work.  \n*Correspondence:  \nSantiago Lima  \n[slima@vcu.edu](slima@vcu.edu)  \n1Department of Biology, Virginia Commonwealth University, Richmond, VA 23284, USA  \n2Massey Cancer Center, Richmond, VA 23298, USA  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/l](vecommons.org/l)icenses/by-nc-nd/4.0/.  \nClark et al. BMC Cancer (2025) 25:1356  \nBackground  \nGSLs are components of the outer layer of the eukaryotic plasma membrane where they serve as mediator","cbCaihZGap2LRS5v","https://ap.wps.com/l/cbCaihZGap2LRS5v","pdf",4056307,16,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Background\n## GSL roles in cancer\n## GSL biosynthesis and B3GNT5 function\n## Evidence linking B3GNT5 to cancers","[{\"question\":\"What role does B3GNT5 play in glycosphingolipid (GSL) metabolism?\",\"answer\":\"B3GNT5 regulates GSL biosynthesis by controlling flux into the lactoside and neolactoside series through production of the Lc3Cer precursor.\"},{\"question\":\"How was B3GNT5 function tested in cancer cells?\",\"answer\":\"Public genetic data were mined for lesions at the B3GNT5 locus and expression effects on outcomes, and HeLa cells were partially depleted of B3GNT5 using CRISPR-Cas9 to assess cancer-associated phenotypes.\"},{\"question\":\"What phenotypic effects occur when B3GNT5 is partially depleted?\",\"answer\":\"Partial depletion increased GlcCer and LacCer, raised chemoresistance, altered EMT marker expression, and decreased activation of multiple RTKs after serum stimulation.\"}]","Regulation of EMT-MET and chemoresistance by the Lc3Cer-synthase B3GNT5 | PDF",[145,149,153,157],{"page_no":8,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e498dd280de963168a41b9bf4f4fb406.webp",983,1310,{"page_no":14,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9e3218ae3933b74b697e37823f18b7d5.webp",982,1309,{"page_no":81,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cebedeb189343dc0e3042b0693f08783.webp",981,1308,{"page_no":19,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f48986117490d7135afa01134fc229a8.webp",980,1306]